Long-term follow-up of kidney transplant recipients admitted to a tertiary care transplant center with SARS-CoV-2

Table 3 Risk factors for intensive care unit admission

Covariate	Univariate analyses			Multivariate analyses
	HR	95%CI	P value	HR	95%CI	P value
Age at SARS-CoV-2 infection diagnosis (per year)	1.01	0.98-1.05	0.35
Male recipient	3.29	1.10-9.88	0.03	3.11	1.04-9.34	0.04
Nonwhite recipient	0.71	0.24-2.13	0.55
Diabetes as a cause of ESKD vs other	1.09	0.42-2.83	0.86
Living donor recipient	0.35	0.10-1.19	0.09	0.38	0.11-1.30	0.12
Previous transplant	0.46	0.13-1.55	0.2
Tacrolimus + MPA + prednisone maintenance vs other	2.07	0.61-7.08	0.24
Prednisone based immunosuppression	0.89	0.21-3.82	0.87
Treatment of rejection before SARS-CoV-2 infection	--	--	--
Vaccinated	0.93	0.38-2.25	0.87
Baseline eGFR pre- SARS-CoV-2 infection (per mL/m2)	1.01	0.99-1.03	0.23
The interval from transplant to COVID-19 (per month)	0.99	0.98-1.01	0.4

COVID-19: Coronavirus disease 2019; SARS-CoV-2: Severe acute respiratory syndrome coronavirus 2; eGFR: Estimated glomerular filtration rate; ESKD: End-stage kidney disease; MPA: Mycophenolic acid.